Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ardent Health (ARDT) Depreciation & Amortization (CF): 2023-2025

Historic Depreciation & Amortization (CF) for Ardent Health (ARDT) over the last 3 years, with Q3 2025 value amounting to $39.2 million.

  • Ardent Health's Depreciation & Amortization (CF) rose 648.61% to $39.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $152.5 million, marking a year-over-year increase of 561.99%. This contributed to the annual value of $146.3 million for FY2024, which is 387.53% up from last year.
  • According to the latest figures from Q3 2025, Ardent Health's Depreciation & Amortization (CF) is $39.2 million, which was up 648.61% from $39.3 million recorded in Q2 2025.
  • In the past 5 years, Ardent Health's Depreciation & Amortization (CF) registered a high of $39.3 million during Q2 2025, and its lowest value of $35.4 million during Q1 2024.
  • For the 3-year period, Ardent Health's Depreciation & Amortization (CF) averaged around $36.9 million, with its median value being $36.3 million (2024).
  • The largest annual percentage gain for Ardent Health's Depreciation & Amortization (CF) in the last 5 years was 825.35% (2025), contrasted with its biggest fall of 240.45% (2025).
  • Quarter analysis of 3 years shows Ardent Health's Depreciation & Amortization (CF) stood at $36.0 million in 2023, then increased by 5.24% to $37.9 million in 2024, then rose by 3.41% to $39.2 million in 2025.
  • Its last three reported values are $39.2 million in Q3 2025, $39.3 million for Q2 2025, and $36.2 million during Q1 2025.